PPARG and pulmonary arterial hypertension: Among these, peroxisome proliferator‐activated receptor gamma (PPARγ)6–7 and bone morphogenetic protein receptor 2 (BMPR2)8–10 have been shown to be decreased in PAH and to be part of the PAH remodeling process.